Radiology

And I do find a lot of the articles very, very interesting.

But when I was at university, the book which I used to love most was Radiology, the Eric Waits book.

Oh, really? I

don't know why.

Welcome to the Radiology Podcasts.

I'm your co-host, Ashwin Singh Parihar from Malincrot Institute of Radiology at Washington University School of Medicine in St. Louis.

If you've been following prostate cancer imaging, you've probably heard about PSMA PET, which has become the go-to agent for detecting recurrence of prostate cancer.

But there is another player in this space, flucitrabine.

The trial is EMPIRE 2, and it compared F18-labeled flucitrabine PET-CT versus gallium-68-PSMA-11 PET-CT for planning salvaged radiation in men with biochemical recurrence following prostatectomy.

Today, we are joined by Drs.

Olainka Ojo and David Schuster from Emory University School of Medicine in Atlanta and the authors of the article F18 Flucicrovine or Gallium PSMA11 PET-CT Guided Salvage Radiotherapy Changes in Post-Prostatectomy Biochemical Recurrence, a Secondary Analysis of the EMPIRE-2 Trial Published in Radiology.

Thanks for joining us.

And I like cutting edge medicine and I like cutting edge things.

Radiology, even at that time, right? So I'm Gen X, I'm 52 years old, right? And even at that time, computers were the space for imaging.

And I like to say this, right? Radiology has always had some version of AI in it.

We're just in a accelerated or different space with AI, but Radiology has always been in the power of computing and radiologists are an interesting physician as well because we don't typically see patients.

You won't see us.

So we're more of what I call the physician physicians.

He put his hands behind his back, stepped away from the table, and did not come near it again.

I asked him to get Dr. Leland from Radiology.

Our building doesn't have a dedicated postmortem CT unit.

We can arrange CT through the hospital when we need one, but it isn't something we do for uncomplicated cases.

I can't get these out unless I'm going to spend a fortune and get these converted into another file format.

So the folks that really spearheaded the movement of DICOM was the ACR, the American College of Radiology.

Okay, okay.

And so they're representing the users, and they're able to make a really strong statement and say, this isn't appropriate.

That's so interesting because either you end up with all of this having to be manually verified or you run the risk that a small number of errors may occur, which you have to undo anyways.

And how do you balance all of that? That's interesting.

The other aspect I wanted to touch on, especially when you brought up the patient identity issue in which patients can be referred by different things, is a recent paper which was published in Radiology for which we had the opportunity to publish an editorial.

So what this paper was, was that they used common generative AI to generate medical images, both normal as and with some abnormalities.

Now, let's dive into this week's show.

Today, I'm speaking with Angela Davis, CEO of the Society for Pediatric Radiology, and Yasmine Fields, CEO of the Society of Breast Imaging.

Ladies, welcome to the show.

Thank you for having us.

Again, children are not small adults.

Oh, interesting.

Well, ladies, I met you at the Intersociety Conference of the American College of Radiology, and this conference, which took place, I guess, last July, brings together the CEOs, executive directors of up to sixty of these radiology associations and board members.

I think maybe it's a board member or a board chair.